Addiction Medicine Round-Up: Key Findings on Vaping, Buprenorphine, and More
Episode Overview
E-cigarettes combined with standard care are more effective for smoking cessation. Buprenorphine reduces the risk of fatal fentanyl overdose by blocking opioid receptors. Initiating medications for alcohol use disorder at hospital discharge significantly reduces mortality and readmissions. Daily cannabis use is linked to higher risks of heart attacks and strokes. 25% of habitual kratom users develop a substance use disorder, mostly mild.
It's harder to overdose if you have buprenorphine in your system, blocking immune opioid receptors.
In this episode of Addiction Medicine Journal Club, Dr. Sonya Del Tredici and Dr. John Keenan provide a roundup of the last ten articles they've reviewed. From vaping as a smoking cessation aid to the protective effects of buprenorphine during fentanyl overdoses, this episode covers a wide range of topics relevant to addiction medicine.
You'll hear about the efficacy of medications for alcohol use disorder at hospital discharge, the cardiovascular risks associated with cannabis use, and the challenges and benefits of using kratom for pain management. Each study is discussed in detail, providing valuable insights and practical takeaways for medical professionals and those interested in addiction treatment. Whether you're a healthcare provider or someone affected by addiction, this episode offers a wealth of information to help you stay informed and make better decisions.
Don't miss out on these important findings that could impact your practice or personal journey.